Evaluation of Dihydrofolate Reductase (Dhfr) Gene, Related to Plasmodium Falciparum Pyrimethamine Resistance in Imported Malaria Cases in Iran
- سال انتشار: 1400
- محل انتشار: مجله تحقیق در پزشکی مولکولی، دوره: 9، شماره: 4
- کد COI اختصاصی: JR_REMJ-9-4_007
- زبان مقاله: انگلیسی
- تعداد مشاهده: 69
نویسندگان
۱Student Research Committee, Mazandaran University of Medical Science, Sari, Iran
Molecular and Cell Biology Research Center (MCBRC), Mazandaran University of Medical Sciences, Sari, Iran
Department of Parasitology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Department of Parasitology and Mycology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran
Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran
Student Research Committee, Mazandaran University of Medical Science, Sari, Iran
Toxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
چکیده
Background: Antimalarial drug resistance is one of the important challenges for governments in the fight against malaria. Molecular surveillance of antimalarial drug resistance supports early detection of how the recommended treatments work. This allows immediate action to reduce any threat and prevent it from spreading. Therefore, the aim of this study was to evaluate the frequency of dihydrofolate reductase (dhfr) mutants in Plasmodium falciparum resistance to pyrimethamine in Iranian malaria patients. Materials and Methods: In ۲۰۲۰, ۲۷ patients (۲۱ males and ۵ females) with imported P. falciparum cases were studied. The nested-PCR technique first confirmed the species in all samples and then amplification was done by the semi-nested-PCR method in order to detect single nucleotide polymorphisms (SNPs) in dhfr gene related to pyrimethamine resistance. Results: All samples in the ۱۸S rRNA gene had species-specific bands for P. falciparum strains. In the sequence analysis of pfdhfr gene amplification after comparison with the standard strain (wild type), ۲۱ patients had a double mutation (C۵۹R+S۱۰۸N) and six patients had a triple mutation (N۵۱I+C۵۹R+S۱۰۸N) of pyrimethamine resistance. Conclusion: The results of this study showed that the susceptibility of P. falciparum to pyrimethamine in the treatment of malaria is significantly reducing. These findings can raise concerns about pyrimethamine resistance in P. falciparum. Due to the high emergence of double and triple mutants related to pyrimethamine resistance, the malaria surveillance and treatment systems in Iran, the use of pyrimethamine should be considered.کلیدواژه ها
Malaria, Plasmodium falciparum, drug resistance, pyrimethamine, pfdhfr, Iranاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.